Erectile dysfunction due to arterial insufficiency
Methodology & AI Transparency ⓘ
Erectile dysfunction due to arterial insufficiency Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Erectile dysfunction due to arterial insufficiency—coded clinically as N52.01 across Men's Health & TRT guidelines—combines PDE5 vascular therapy [Erectile dysfunction due to arterial insufficiency N52.01] with structured follow-up of Morning Total & in Erectile dysfunction due to arterial insufficiency (N52.01: Free Testosterone (2x) (Total 500–900 ng/dL; Free 110–210 pg/mL (N52.01)).
- 2 Real-world patient consensus: Clinical coding for Erectile dysfunction due to arterial insufficiency uses ICD-10 N52.01 across Men's Health & TRT specialty care.
- 3 Typical cash cost range: Differential triage of Erectile dysfunction due to arterial insufficiency (N52.01) utilizes PDE5 vascular therapy [Erectile dysfunction due to arterial insufficiency N52.01].
- 4 Top reported side effects / signs: Key Men's Health & TRT biomarkers for Erectile dysfunction due to arterial insufficiency (N52.01): Ultrasensitive Estradiol & in Erectile dysfunction due to arterial insufficiency (N52.01: ApoB) & Morning Total & in Erectile dysfunction due to arterial insufficiency (N52.01: Free Testosterone (2x) (Total 500–900 ng/dL; Free 110–210 pg/mL (N52.01)).
Ask our AI Specialists anything about Erectile dysfunction due to arterial insufficiency
What Is Erectile dysfunction due to arterial insufficiency?
Erectile dysfunction due to arterial insufficiency—coded clinically as N52.01 across Men's Health & TRT guidelines—combines PDE5 vascular therapy [Erectile dysfunction due to arterial insufficiency N52.01] with structured follow-up of Morning Total & in Erectile dysfunction due to arterial insufficiency (N52.01: Free Testosterone (2x) (Total 500–900 ng/dL; Free 110–210 pg/mL (N52.01)).
Pathophysiology, Underlying Causes & Clinical Presentation
Erectile dysfunction due to arterial insufficiency (N52.01) alters men's health & trt homeostasis through microvascular arterial inflow in Erectile dysfunction due to arterial insufficiency (N52.01: reduction); clinical remission targets Morning Total & in Erectile dysfunction due to arterial insufficiency (N52.01: Free Testosterone (2x) within Total 500–900 ng/dL; Free 110–210 pg/mL (N52.01).
Common Symptoms & Clinical Signs
- • Presentation of Erectile dysfunction due to arterial insufficiency (N52.01): blunted motivation, depressed in Erectile dysfunction due to arterial insufficiency (N52.01: mood, or declining)
- • Secondary Erectile dysfunction due to arterial insufficiency clinical sign: two consecutive morning in Erectile dysfunction due to arterial insufficiency (N52.01: total testosterone readings)
- • Symptom flares in Erectile dysfunction due to arterial insufficiency correlating with Ultrasensitive Estradiol & in Erectile dysfunction due to arterial insufficiency (N52.01: ApoB) deviation outside E2 20–38 pg/mL; ApoB < 80 mg/dL (N52.01)
- • Functional men's health & trt impact requiring PDE5 vascular therapy [Erectile dysfunction due to arterial insufficiency N52.01] evaluation (N52.01)
Erectile dysfunction due to arterial insufficiency Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | N52.01 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Men's Health, Testosterone & Sexual Function | NLM Clinical Tables |
| Diagnostic / Lab Marker: Ultrasensitive Estradiol & in Erectile dysfunction due to arterial insufficiency (N52.01: ApoB) | E2 20–38 pg/mL; ApoB < 80 mg/dL (N52.01) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Morning Total & in Erectile dysfunction due to arterial insufficiency (N52.01: Free Testosterone (2x) | Total 500–900 ng/dL; Free 110–210 pg/mL (N52.01) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: LH, FSH & in Erectile dysfunction due to arterial insufficiency (N52.01: SHBG) | LH/FSH 2.5 – 8.0 mIU/mL (N52.01) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Erectile dysfunction due to arterial insufficiency
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Iohexol Omnipaque • RxCUI RXN-808302466-1733 | Radiographic Contrast Agent | 83% | $0.6200 | $ 33.61 /mo |
| Epinephrine Adrenalin, Neffy • RxCUI 1660014 | alpha-Adrenergic Agonist | 86% | $127.8321 | $ 185.00 /mo |
| Iopamidol Isovue 200, Isovue • RxCUI RXN-02701314-1729 | Radiographic Contrast Agent | 81% | $0.2400 | $ 18.22 /mo |
| Ethiodized Oil Lipiodol • RxCUI RXN-676841901-2887 | Radiographic Contrast Agent | 84% | $2.8400 | $ 123.52 /mo |
| Iopromide Ultravist • RxCUI RXN-50419348-2522 | Radiographic Contrast Agent | 88% | $3.4300 | $ 147.42 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Erectile dysfunction due to arterial insufficiency)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Testosterone Therapy for Late-Onset Hypogonadism Improves Erectile: What a 1,458-Participant Study Found TTh achieved a significant improvement in the IIEF-EFD score of hypogonadal men compared with placebo, especially in those who received testosterone gel, were treated for over 30 weeks, and had no comorbidities. Urologia internationalis • 2022-01-15 • Meta-Analysis | N = 1,458 | 99/100 | PMID 34856556 ↗ |
| New Insights on Benefits and safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to: What a 1,144-Participant Study Found However, therapy discontinuation due to pain and AEs did not increase with increase in AEs. American journal of men's health • 2020-01-15 • Meta-Analysis | N = 1,144 | 94/100 | PMID 33342335 ↗ |
| New Insights on Monotherapies and Combination Therapy of Tamsulosin and Tadalafil for Treating: What a 1,531-Participant Study Found Tadalafil combined with tamsulosin was more effective in the treatment of male LUTS/BPH, with or without ED, on the improvement of total IPSS, QoL, and Qmax. Urologia internationalis • 2024-01-15 • Meta-Analysis | N = 1,531 | 94/100 | PMID 38081154 ↗ |
| Combination Therapies vs. Single-drug treatment: Which Works Better for Erectile Dysfunction? A total of 44 studies included 3853 men with a mean (SD) age of 55.8 (11.9) years. JAMA network open • 2021-02-01 • Meta-Analysis | N = 3,853 | 94/100 | PMID 33599772 ↗ |
| New Insights on Benefits and safety of tadalafil 5 mg once-daily in Asian men with both lower: What a 361-Participant Study Found Tadalafil is efficacious and well tolerated in the treatment of Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction. International journal of urology : official journal of the Japanese Urological Association • 2019-02-15 • Phase III Randomized Trial | N = 361 | 93/100 | PMID 30362173 ↗ |
Erectile dysfunction due to arterial insufficiency Patient Community & “People Like Me” Threads
Filter Erectile dysfunction due to arterial insufficiency community threads and patient logs by age, biological sex, dosage, and treatment duration.